Cite
APA Citation
Wang, X., Hruska, M., Chan, P., Ahmad, A., Freeman, J., Horga, M. A., Hillson, J., Kansra, V., & Lopez‐Talavera, J. (n.d.). derivation of Phase 3 dosing for peginterferon lambda‐1a in chronic hepatitis C, Part 1: Modeling optimal treatment duration and sustained virologic response rates. Journal of clinical pharmacology, 55, 63–72. http://access.bl.uk/ark:/81055/vdc_100025007210.0x00004b